Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Tarsus Pharmaceuticals, Inc. |
|---|---|
| Ticker | TARS |
| CIK | 0001819790 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Tarsus Pharmaceuticals, Inc. |
Status
| Zuletzt geprüft | 2026-03-22 23:54:04.40131 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,231 | 67.00 | -283,477.00 | -77,6% | |
| 2026-03-19 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,440 | 67.00 | -297,480.00 | -81,5% | |
| 2026-03-19 | Lin Elizabeth Yeu | Officer, Chief Medical Officer | Open Market Sale | -390 | 67.00 | -26,130.00 | -7,2% | |
| 2026-03-19 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,440 | 67.00 | -297,480.00 | -81,5% | |
| 2026-03-19 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,186 | 67.00 | -146,462.00 | -40,1% | |
| 2026-03-19 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,174 | 67.00 | -279,658.00 | -76,6% | |
| 2026-03-19 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -4,589 | 67.00 | -307,463.00 | -84,2% | |
| 2026-03-19 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,174 | 67.00 | -279,658.00 | -76,6% | |
| 2026-03-19 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,186 | 67.00 | -146,462.00 | -40,1% | |
| 2026-03-19 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -11,964 | 67.00 | -801,588.00 | -219,5% | |
| 2026-03-19 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,231 | 67.00 | -283,477.00 | -77,6% | |
| 2026-03-19 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -4,589 | 67.00 | -307,463.00 | -84,2% | |
| 2026-03-18 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,133 | 68.71 | -146,558.43 | -40,1% | |
| 2026-03-18 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,071 | 68.71 | -279,718.41 | -76,6% | |
| 2026-03-18 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,133 | 68.71 | -146,558.43 | -40,1% | |
| 2026-03-18 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -11,667 | 68.71 | -801,639.57 | -219,5% | |
| 2026-03-18 | Lin Elizabeth Yeu | Officer, Chief Medical Officer | Open Market Sale | -379 | 68.71 | -26,041.09 | -7,1% | |
| 2026-03-18 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -3,610 | 68.71 | -248,043.10 | -67,9% | |
| 2026-03-18 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -3,610 | 68.71 | -248,043.10 | -67,9% | |
| 2026-03-18 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,330 | 68.71 | -297,514.30 | -81,5% | |
| 2026-03-18 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,330 | 68.71 | -297,514.30 | -81,5% | |
| 2026-03-18 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,071 | 68.71 | -279,718.41 | -76,6% | |
| 2026-03-18 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,125 | 68.71 | -283,428.75 | -77,6% | |
| 2026-03-18 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,125 | 68.71 | -283,428.75 | -77,6% | |
| 2026-03-17 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,286 | 69.42 | -297,534.12 | -81,5% | |
| 2026-03-17 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,084 | 69.42 | -283,511.28 | -77,6% | |
| 2026-03-17 | Wahl Bryan | Officer, General Counsel | Open Market Sale | -4,084 | 69.42 | -283,511.28 | -77,6% | |
| 2026-03-17 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,029 | 69.42 | -279,693.18 | -76,6% | |
| 2026-03-17 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -4,029 | 69.42 | -279,693.18 | -76,6% | |
| 2026-03-17 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -4,286 | 69.42 | -297,534.12 | -81,5% | |
| 2026-03-17 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -3,125 | 69.42 | -216,937.50 | -59,4% | |
| 2026-03-17 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -3,125 | 69.42 | -216,937.50 | -59,4% | |
| 2026-03-17 | Lin Elizabeth Yeu | Officer, Chief Medical Officer | Open Market Sale | -375 | 69.42 | -26,032.50 | -7,1% | |
| 2026-03-17 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -10,972 | 69.42 | -761,676.24 | -208,6% | |
| 2026-03-17 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,111 | 69.42 | -146,545.62 | -40,1% | |
| 2026-03-17 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -2,111 | 69.42 | -146,545.62 | -40,1% | |
| 2026-03-16 | LINK WILLIAM J PHD | Director | Open Market Sale | -3,629 | 68.09 | -247,098.61 | -67,7% | |
| 2026-03-16 | LINK WILLIAM J PHD | Director | Open Market Sale | -493 | 69.75 | -34,386.75 | -9,4% | |
| 2026-03-16 | LINK WILLIAM J PHD | Director | Open Market Sale | -8,378 | 69.03 | -578,333.34 | -158,4% | |
| 2026-03-04 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -8,366 | 76.67 | -641,421.22 | -175,7% | |
| 2026-03-04 | Neervannan Seshadri | Officer, Chief Operating Officer | Open Market Sale | -8,366 | 76.67 | -641,421.22 | -175,7% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -5,715 | 80.09 | -457,714.35 | -125,3% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -8,122 | 80.71 | -655,526.62 | -179,5% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -835 | 81.90 | -68,386.50 | -18,7% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -893 | 82.93 | -74,056.49 | -20,3% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -5,715 | 80.09 | -457,714.35 | -125,3% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -8,122 | 80.71 | -655,526.62 | -179,5% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -835 | 81.90 | -68,386.50 | -18,7% | |
| 2026-01-02 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -893 | 82.93 | -74,056.49 | -20,3% | |
| 2025-12-24 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -557 | 83.54 | -46,531.78 | -12,7% | |
| 2025-12-24 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -5,443 | 82.41 | -448,557.63 | -122,8% | |
| 2025-12-16 | Lin Elizabeth Yeu | Officer, Chief Medical Officer | Open Market Sale | -2,078 | 79.50 | -165,201.00 | -45,2% | |
| 2025-12-16 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -7,397 | 80.10 | -592,499.70 | -162,3% | |
| 2025-12-16 | Whitfield Dianne C. | Officer, Chief Human Resources Officer | Open Market Sale | -7,397 | 80.10 | -592,499.70 | -162,3% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -1,148 | 82.39 | -94,583.72 | -25,9% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -5,680 | 80.71 | -458,432.80 | -125,5% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -5,046 | 80.80 | -407,716.80 | -111,7% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -5,046 | 80.80 | -407,716.80 | -111,7% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -4,766 | 81.50 | -388,429.00 | -106,4% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -5,680 | 80.71 | -458,432.80 | -125,5% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -1,148 | 82.39 | -94,583.72 | -25,9% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -6,306 | 81.75 | -515,515.50 | -141,2% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -4,766 | 81.50 | -388,429.00 | -106,4% | |
| 2025-12-15 | LINK WILLIAM J PHD | Director | Open Market Sale | -6,306 | 81.75 | -515,515.50 | -141,2% | |
| 2025-09-24 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -6,000 | 55.37 | -332,220.00 | -91,0% | |
| 2025-09-08 | LINK WILLIAM J PHD | Director | Open Market Sale | -27,116 | 57.00 | -1,545,612.00 | -423,3% | |
| 2025-09-08 | LINK WILLIAM J PHD | Director | Open Market Sale | -27,116 | 57.00 | -1,545,612.00 | -423,3% | |
| 2025-08-11 | Azamian Bobak R. | Director, Officer, President/CEO and Board Chair | Open Market Sale | -6,000 | 50.00 | -300,000.00 | -82,2% | |
| 2025-06-17 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -13,608 | 40.42 | -550,035.36 | -150,6% | |
| 2025-06-17 | Farrow Jeffrey S | Officer, See Remarks | Open Market Sale | -13,608 | 40.42 | -550,035.36 | -150,6% | |
| 2025-06-16 | Lin Elizabeth Yeu | Officer, Chief Medical Officer | Open Market Sale | -1,006 | 41.08 | -41,326.48 | -11,3% | |
| 2025-06-09 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -17,500 | 43.76 | -765,800.00 | -209,7% | |
| 2025-06-09 | Mottiwala Aziz | Officer, Chief Commercial Officer | Open Market Sale | -17,500 | 43.76 | -765,800.00 | -209,7% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.